Table of Content

1 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Overview
1.1 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Product Scope
1.2 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Segment by Type
1.2.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Bactrim
1.2.3 Vancomycin
1.2.4 Clindamycin
1.2.5 Minocycline
1.3 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Segment by Application
1.3.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Clinic
1.4 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Price Trends (2016-2027)

2 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Estimates and Forecasts by Region
2.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Estimates and Projections (2016-2027)
2.4.3 China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Estimates and Projections (2016-2027)
2.4.6 India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Estimates and Projections (2016-2027)

3 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Competition Landscape by Players
3.1 Global Top Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Players by Sales (2016-2021)
3.2 Global Top Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Players by Revenue (2016-2021)
3.3 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs as of 2020)
3.4 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size by Type
4.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Price by Type (2016-2021)
4.2 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Price Forecast by Type (2022-2027)

5 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size by Application
5.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Price by Application (2016-2021)
5.2 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Price Forecast by Application (2022-2027)

6 North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Facts & Figures
6.1 North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Company
6.1.1 North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Company (2016-2021)
6.1.2 North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Company (2016-2021)
6.2 North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Type
6.2.1 North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Application
6.3.1 North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Application (2022-2027)

7 Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Facts & Figures
7.1 Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Company
7.1.1 Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Company (2016-2021)
7.1.2 Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Company (2016-2021)
7.2 Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Type
7.2.1 Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Application
7.3.1 Europe 123 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 123 Sales Breakdown by Application (2022-2027)

8 China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Facts & Figures
8.1 China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Company
8.1.1 China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Company (2016-2021)
8.1.2 China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Company (2016-2021)
8.2 China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Type
8.2.1 China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Type (2022-2027)
8.3 China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Application
8.3.1 China 145 Sales Breakdown by Application (2016-2021)
8.3.2 China 145 Sales Breakdown by Application (2022-2027)

9 Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Facts & Figures
9.1 Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Company
9.1.1 Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Company (2016-2021)
9.1.2 Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Company (2016-2021)
9.2 Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Type
9.2.1 Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Facts & Figures
10.1 Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Company
10.1.1 Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Facts & Figures
11.1 India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Company
11.1.1 India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Company (2016-2021)
11.1.2 India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Company (2016-2021)
11.2 India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Type
11.2.1 India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Type (2022-2027)
11.3 India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Application
11.3.1 India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Business
12.1 Takeda Pharmaceutical
12.1.1 Takeda Pharmaceutical Corporation Information
12.1.2 Takeda Pharmaceutical Business Overview
12.1.3 Takeda Pharmaceutical Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Takeda Pharmaceutical Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
12.1.5 Takeda Pharmaceutical Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Business Overview
12.2.3 Merck Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
12.2.5 Merck Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Corporation Information
12.3.2 AstraZeneca Business Overview
12.3.3 AstraZeneca Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 AstraZeneca Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
12.3.5 AstraZeneca Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Corporation Information
12.4.2 GlaxoSmithKline Business Overview
12.4.3 GlaxoSmithKline Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 GlaxoSmithKline Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
12.4.5 GlaxoSmithKline Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Business Overview
12.5.3 Pfizer Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Pfizer Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
12.5.5 Pfizer Recent Development
12.6 Cubist Pharmaceuticals
12.6.1 Cubist Pharmaceuticals Corporation Information
12.6.2 Cubist Pharmaceuticals Business Overview
12.6.3 Cubist Pharmaceuticals Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Cubist Pharmaceuticals Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
12.6.5 Cubist Pharmaceuticals Recent Development
12.7 ViroPharma
12.7.1 ViroPharma Corporation Information
12.7.2 ViroPharma Business Overview
12.7.3 ViroPharma Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 ViroPharma Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
12.7.5 ViroPharma Recent Development
12.8 Forest Laboratories
12.8.1 Forest Laboratories Corporation Information
12.8.2 Forest Laboratories Business Overview
12.8.3 Forest Laboratories Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Forest Laboratories Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
12.8.5 Forest Laboratories Recent Development
12.9 Theravance
12.9.1 Theravance Corporation Information
12.9.2 Theravance Business Overview
12.9.3 Theravance Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Theravance Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
12.9.5 Theravance Recent Development

13 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Manufacturing Cost Analysis
13.1 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs
13.4 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Distributors List
14.3 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Customers

15 Market Dynamics
15.1 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Trends
15.2 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Drivers
15.3 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Challenges
15.4 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units) by Region (2016-2021)
Table 5. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Share by Region (2016-2021)
Table 8. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Share by Company (2016-2021)
Table 14. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Share by Company (2016-2021)
Table 16. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs as of 2020)
Table 17. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Average Price (US$/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units) by Type (2016-2021)
Table 22. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Share by Type (2016-2021)
Table 23. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Price (US$/Unit) by Type (2016-2021)
Table 25. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Share by Type (2022-2027)
Table 26. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Share by Type (2022-2027)
Table 28. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Price (US$/Unit) by Type (2022-2027)
Table 29. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units) by Application (2016-2021)
Table 30. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Share by Application (2016-2021)
Table 31. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Price (US$/Unit) by Application (2016-2021)
Table 33. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units) by Application (2022-2027)
Table 34. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Share by Application (2022-2027)
Table 35. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Share by Application (2022-2027)
Table 37. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Price (US$/Unit) by Application (2022-2027)
Table 38. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units) by Company (2016-2021)
Table 39. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2016-2021) & (K Units)
Table 43. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2022-2027) & (K Units)
Table 45. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2016-2021) & (K Units)
Table 47. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2022-2027) & (K Units)
Table 49. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units) by Company (2016-2021)
Table 51. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2016-2021) & (K Units)
Table 55. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2022-2027) & (K Units)
Table 57. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2016-2021) & (K Units)
Table 59. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2022-2027) & (K Units)
Table 61. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2022-2027)
Table 62. China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units) by Company (2016-2021)
Table 63. China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Company (2016-2021)
Table 64. China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2016-2021) & (K Units)
Table 67. China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2016-2021)
Table 68. China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2022-2027) & (K Units)
Table 69. China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2022-2027)
Table 70. China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2016-2021) & (K Units)
Table 71. China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2016-2021)
Table 72. China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2022-2027) & (K Units)
Table 73. China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units) by Company (2016-2021)
Table 75. Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2016-2021) & (K Units)
Table 79. Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2022-2027) & (K Units)
Table 81. Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2016-2021) & (K Units)
Table 83. Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2022-2027) & (K Units)
Table 85. Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2022-2027)
Table 98. India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units) by Company (2016-2021)
Table 99. India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Company (2016-2021)
Table 100. India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2016-2021) & (K Units)
Table 103. India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2016-2021)
Table 104. India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2022-2027) & (K Units)
Table 105. India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2022-2027)
Table 106. India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2016-2021) & (K Units)
Table 107. India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2016-2021)
Table 108. India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2022-2027) & (K Units)
Table 109. India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2022-2027)
Table 110. Takeda Pharmaceutical Corporation Information
Table 111. Takeda Pharmaceutical Description and Business Overview
Table 112. Takeda Pharmaceutical Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Takeda Pharmaceutical Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Product
Table 114. Takeda Pharmaceutical Recent Development
Table 115. Merck Corporation Information
Table 116. Merck Description and Business Overview
Table 117. Merck Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Merck Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Product
Table 119. Merck Recent Development
Table 120. AstraZeneca Corporation Information
Table 121. AstraZeneca Description and Business Overview
Table 122. AstraZeneca Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. AstraZeneca Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Product
Table 124. AstraZeneca Recent Development
Table 125. GlaxoSmithKline Corporation Information
Table 126. GlaxoSmithKline Description and Business Overview
Table 127. GlaxoSmithKline Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. GlaxoSmithKline Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Product
Table 129. GlaxoSmithKline Recent Development
Table 130. Pfizer Corporation Information
Table 131. Pfizer Description and Business Overview
Table 132. Pfizer Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Pfizer Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Product
Table 134. Pfizer Recent Development
Table 135. Cubist Pharmaceuticals Corporation Information
Table 136. Cubist Pharmaceuticals Description and Business Overview
Table 137. Cubist Pharmaceuticals Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Cubist Pharmaceuticals Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Product
Table 139. Cubist Pharmaceuticals Recent Development
Table 140. ViroPharma Corporation Information
Table 141. ViroPharma Description and Business Overview
Table 142. ViroPharma Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. ViroPharma Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Product
Table 144. ViroPharma Recent Development
Table 145. Forest Laboratories Corporation Information
Table 146. Forest Laboratories Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 147. Forest Laboratories Description and Business Overview
Table 148. Forest Laboratories Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Product
Table 149. Forest Laboratories Recent Development
Table 150. Theravance Corporation Information
Table 151. Theravance Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
Table 152. Theravance Description and Business Overview
Table 153. Theravance Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Product
Table 154. Theravance Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Distributors List
Table 158. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Customers List
Table 159. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Trends
Table 160. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Drivers
Table 161. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Challenges
Table 162. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Product Picture
Figure 2. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Bactrim Product Picture
Figure 4. Vancomycin Product Picture
Figure 5. Clindamycin Product Picture
Figure 6. Minocycline Product Picture
Figure 7. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application in 2021 & 2027
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 13. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Price Trends Growth Rate (2016-2027) (US$/Unit)
Figure 14. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 18. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Players Market Share by Revenue in Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs: 2016 & 2020
Figure 29. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Share by Type (2016-2021)
Figure 31. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Share by Application (2016-2021)
Figure 33. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type in 2020
Figure 35. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application in 2020
Figure 36. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type in 2020
Figure 37. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application in 2020
Figure 38. China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type in 2020
Figure 39. China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application in 2020
Figure 40. Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type in 2020
Figure 41. Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application in 2020
Figure 42. Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type in 2020
Figure 43. Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application in 2020
Figure 44. India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type in 2020
Figure 45. India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs
Figure 48. Manufacturing Process Analysis of Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs
Figure 49. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed